Quality of Life in schizophrenic patients - Quality
Study identifier:NIS-NBE-SER-2006/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
QUALITY: A non-interventional study evaluating Quality Of Life in schizophrenic patients treated with atypical antipsychotics, in the ambulatory setting. A 9-month, observational, multicentric prospective study.
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
124
Study type
Observational
Age
18 Years - 65 Years
Date
Study Start Date: 01 Oct 2007
Primary Completion Date: 01 Oct 2009
Study Completion Date: 01 Oct 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Prof Vermylen
UZ Leuven
